Benitec Biopharma (BNTC) Shares Outstanding (2019 - 2025)

Benitec Biopharma (BNTC) has 5 years of Shares Outstanding (Entity) data on file, last reported at $4.1 million in Q2 2024.

• For the quarter ending Q2 2024, Shares Outstanding (Entity) rose 146.68% year-over-year to $4.1 million; the trailing twelve-month figure through Jun 2024 stood at $4.1 million (up 146.68% YoY), and the FY2024 full-year result was $4.1 million, up 146.68% from the prior year.
• Shares Outstanding (Entity) rose to $4.1 million in Q2 2024, from $2.7 million in the prior quarter.
• In the past five years, Shares Outstanding (Entity) ranged from a high of $4.1 million in Q2 2024 to a low of $65195.0 in Q2 2020.
• A 5-year average of $1.2 million and a median of $480659.0 in 2021 frame the typical range for Shares Outstanding (Entity).
• Across the five-year window, Shares Outstanding (Entity) surged 637.26% in 2021 and soared 32.85% in 2022, its largest moves.
• Tracing BNTC's Shares Outstanding (Entity) over 5 years: stood at $267070.0 in 2020, then surged by 79.97% to $480659.0 in 2021, then jumped by 242.42% to $1.6 million in 2022, then jumped by 57.51% to $2.6 million in 2023, then surged by 56.62% to $4.1 million in 2024.
• Business Quant data shows BNTC's Shares Outstanding (Entity) at $4.1 million in Q2 2024, $2.7 million in Q1 2024, and $2.6 million in Q4 2023.